Immunocore transitions to U.S. domestic issuer effective January 1, 2024

Immunocore Holdings plc

Will file periodic reports on U.S. domestic issuer forms, which are more detailed and require faster filing.
Previously qualified as a foreign private issuer prior to January 1, 2024.
Company lists disclosure channels: SEC filings, press releases, website, LinkedIn, and X account.

item 7.01

Immunocore Holdings plc filing history →

Source: SEC EDGAR

accession 0001140361-24-000012

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.